SCHEMBL4810219

SCHEMBL4810219

CCc1ccc(C(O)c2cc(F)ccc2OCc2ccccc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.43
SLC6A5 Q9Y345 1/20 0.43
FFAR4 Q5NUL3 4/20 0.41
FFAR1 O14842 2/20 0.41
MRGPRX4 Q96LA9 2/20 0.41
LIPE Q05469 1/20 0.40
MAPT P10636 5/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
LMNA P02545 2/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CSF1R P07333 1/20 0.39
AKR1C3 P42330 1/20 0.39
HTR1A P08908 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1539311 0.87 LIPE (0.45) MRGPRX4LIPEMAPTKDM4EALDH1A1
SCHEMBL2572231 0.87 FFAR1 (0.48) SLC6A9SLC6A5FFAR4FFAR1MAPT
SCHEMBL31041187 0.82 SLC6A9 (0.47) SLC6A9SLC6A5LIPEMAPTKDM4E
SCHEMBL16797668 0.80 FFAR4 (0.43) SLC6A9SLC6A5FFAR4FFAR1MRGPRX4
SCHEMBL2580792 0.77 FFAR1 (0.48) FFAR4FFAR1MAPTALDH1A1LMNA
SCHEMBL2575339 0.77 SLC6A9 (0.60) SLC6A9SLC6A5MRGPRX4LIPEMAPT
SCHEMBL323922 0.77 SLC6A9 (0.44) SLC6A9SLC6A5MRGPRX4MAPTALDH1A1
SCHEMBL3223738 0.76 SMN1; SMN2 (0.39) FFAR4MAPTSMN1; SMN2RAB9AL3MBTL1
SCHEMBL2576276 0.76 LMNA (0.52) MRGPRX4MAPTALDH1A1LMNAHTR1A
SCHEMBL18893982 0.76 SLC6A9 (0.46) SLC6A9SLC6A5MRGPRX4LIPEMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414072-B2 Aryl 5-thio-β-d-glucopyranoside derivatives and therapeutic agents for diabetes containing the same TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-08-19 US disclosed
US-7250522-B2 Method for selective preparation of aryl 5-thio-β-D-aldohexopyranosides TAISHO PHARMACEUTICAL CO., LTD. (JP) 2007-07-31 US disclosed
US-20050256317-A1 Process for selective production of aryl 5-thio-beta-d- aldohexopyranosides TAISHO PHARMACEUTICAL CO., LTD. (JP) 2005-11-17 US disclosed
US-20050209309-A1 Aryl 5-thio-beta-d-glucopyranoside derivatives and remedies for diabetes containing the same TAISHO PHARMACEUTICAL CO., LTD. 2005-09-22 US disclosed
EP-1541578-A1 PROCESS FOR SELECTIVE PRODUCTION OF ARYL 5-THIO-BETA-D-ALDOHEXOPYRANOSIDES TAISHO PHARMACEUTICAL CO., LTD (JP) 2005-06-15 EP disclosed
EP-1528066-A1 ARYL 5-THIO-D-GLUCOPYRANOSIDE DERIVATIVES AND REMEDIES FOR DIABETES CONTAINING THE SAME TAISHO PHARMACEUTICAL CO., LTD (JP) 2005-05-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256317-A1 Process for selective production of aryl 5-thio-beta-d- aldohexopyranosides ALDOA, DERA, AKR1D1 SLC6A9 2793/4885SLC6A5 1406/4885FFAR4 1510/4885
US-20050209309-A1 Aryl 5-thio-beta-d-glucopyranoside derivatives and remedies for diabetes containing the same SLC5A2, SLC5A1, UGGT1 SLC6A9 78/4885SLC6A5 25/4885FFAR4 1481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.